세계의 디지털 치료 (DTx) 시장 2024-2030 : 용도별 (당뇨병, 비만, 금연, 호흡기 질환), 최종 용도별 (환자, 의료 제공자, 지불자, 고용주), 지역별

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Process
1.2.1 Information Procurement
1.3 Research Scope and Assumptions
1.4 Research Methodology
1.5 Objectives
1.5.1 Objective – 1
1.5.2 Objective – 2
1.5.3 Objective – 3
1.6 List to Data Sources
Chapter 2 Executive Summary
2.1 Executive Summary
2.2 Digital Therapeutics Snapshot
2.3 Digital Therapeutics Segment Snapshot
2.4 Digital Therapeutics Competitive Landscape Snapshot
Chapter 3 Digital Therapeutics Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.2 Ancillary market outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.3 Increasing prevalence of chronic diseases
3.2.4 Increasing smartphone penetration in developed and developing countries
3.2.5 Cost-effectiveness of digital health technology for providers and patients
3.2.6 Increasing demand for integrated healthcare systems and patient-centric care
3.2.5 Market Restraint Analysis
3.2.6 Concerns over data protection & privacy
3.2.7 Reluctance in adoption by certain market stakeholders
3.2.7 Porter Five Force Analysis
3.2.8 Threat of New Entrants: Low
3.2.9 Competitive Rivalry: High
3.2.10 Threat of Substitutes: Low
3.2.11 Bargaining Power of Buyers: High
3.2.12 Bargaining Power of Suppliers: Low
3.2.13 Pestle Analysis
3.2.14 Political and legal
3.2.15 Economical & Social
3.2.16 Technological
3.3 Impact of COVID-19 on the Digital Therapeutics
Chapter 4 Digital Therapeutics Market: Application Estimates & Trend Analysis
4.1 Digital Therapeutics Market: Application Movement Analysis
4.2 Market Definition and Scope
4.3 Digital Therapeutics Market Estimates & Forecast, By Application (USD Million)
4.4 Diabetes
4.5 Obesity
4.6 CVD
4.7Smoking Cessation
4.8 CNS Diseases
4.9 OTHERS
Chapter 5 Digital Therapeutics Market: End-Use Estimates & Trend Analysis
5.1 Digital Therapeutics Market: End-Use Movement Analysis
5.2 Market Definition and Scope
5.3 Digital Therapeutics Market Estimates & Forecast, By End-Use (USD Million)
5.4 Patients
5.5 Providers
5.6 Payers
5.7 Employers
5.8 Other End-uses
Chapter 6 Digital Therapeutics: Regional Estimates & Trend Analysis, by Application, and End-Use
6.1 North America
6.1.1 Competitive Scenario
6.1.2 North America Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million):
6.1.3 U.S.
6.1.3.1 Key Country Dynamics
6.1.3.2 Regulatory framework
6.1.3.3 U.S. Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.1.4 Canada
6.1.4.1 Key Country Dynamics
6.1.4.2 Regulatory framework
6.1.4.3 Canada Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2 Europe
6.2.1 Competitive Scenario
6.2.2 Europe Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.3 UK
6.2.3.1 Key Country Dynamics
6.2.3.2 Regulatory framework
6.2.3.3 UK Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.4 Germany
6.2.4.1 Key Country Dynamics
6.2.4.2 Regulatory framework
6.2.4.3 Germany Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.5 France
6.2.5.1 Key Country Dynamics
6.2.5.2 Regulatory framework
6.2.5.3 France Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.6 Spain
6.2.6.1 Key Country Dynamics
6.2.6.2 Regulatory framework
6.2.6.3 Spain Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.7 Italy
6.2.7.1 Key Country Dynamics
6.2.7.2 Regulatory framework
6.2.7.2 Italy Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.8 Denmark
6.2.8.1 Key Country Dynamics
6.2.8.2 Regulatory framework
6.2.8.3 Denmark Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.9 Sweden
6.2.9.1 Key Country Dynamics
6.2.9.2 Regulatory framework
6.2.9.3 Sweden Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.10 Norway
6.2.10.1 Key Country Dynamics
6.2.10.2 Regulatory framework
6.2.10.3 Norway Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3 Asia Pacific
6.3.1 Competitive Scenario
6.3.2 Asia Pacific Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.3 Japan
6.3.3.1 Key Country Dynamics
6.3.3.2 Regulatory framework
6.3.3.3 Japan Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.4 China
6.3.4.1 Key Country Dynamics
6.3.4.2 Regulatory framework
6.3.4.3 China Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.5 India
6.3.5.1 Key Country Dynamics
6.3.5.2 Regulatory framework
6.3.5.3 India Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.6 Australia
6.3.6.1 Key Country Dynamics
6.3.6.2 Regulatory framework
6.3.6.3 Australia Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.7 South korea
6.3.7.1 Key Country Dynamics
6.3.7.2 Regulatory framework
6.3.7.3 South korea Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.8 Thailand
6.3.8.1 Key Country Dynamics
6.3.8.2 Regulatory framework
6.3.8.3 ThailandDigital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4 Latin America
6.4.1 Competitive Scenario:
6.4.2 Latin America Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.3 Brazil
6.4.3.1 Key Country Dynamics
6.4.3.2 Regulatory framework
6.4.3.3 BrazilDigital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.4 Mexico
6.4.4.1 Key Country Dynamics
6.4.4.2 Regulatory framework
6.4.4.3 MexicoDigital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.5 Argentina
6.4.5.1 Key Country Dynamics
6.4.5.2 Regulatory framework
6.4.5.2 Argentina Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5 MEA
6.5.1 COMPETITIVE SCENARIO
6.5.2 MEA Digital Therapeutics Market Estimates And ForecastsS, 2018 – 2030 (USD Million)
6.5.3 South Africa
6.5.3.1 Key Country Dynamics
6.5.3.2 Regulatory framework
6.5.3.3 South Africa Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5.4 Saudi arabia
6.5.4.1 Key Country Dynamics
6.5.4.2 Regulatory framework
6.5.4.3 Saudi arabia Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5.5 UAE
6.5.5.1 Key Country Dynamics
6.5.5.2 Regulatory framework
6.5.5.3 UAE Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5.6 Israel
6.5.6.1 Key Country Dynamics
6.5.6.2 Regulatory framework
6.5.6.3 Israel Digital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5.7 Kuwait
6.5.7.1 Key Country Dynamics
6.5.7.2 Regulatory framework
6.5.7.3 KuwaitDigital Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Heat Map Analysis
7.2 Participant Categorization
7.2.1 Company Categorization Analysis
Chapter 8 Company Profile
8.1. OMADA Health, Inc.
8.2. Welldoc, Inc.
8.3. 2Morrow, Inc.
8.4. Teladoc Health, Inc.
8.5. Propeller Health
8.6. CANARY HEALTH
8.7. Noom, Inc.
8.8. Fitbit, LLC
8.9. Pear Therapeutics, Inc.
8.10. Akili Interactive Labs, Inc.
8.11. HYGIEIA
8.12. DarioHealth, Corp.
8.13. GAIA AG
8.14. BigHealth
8.15. Limbix Health, Inc.
8.16 Key Strategies Adopted by Players Include:
8.16.1 Expansion
8.16.2 Acquisition
8.16.3 Collaborations
8.16.4 Others